Matheus C. Casotti ^1* Débora D. Meira ^1* Aléxia S. Zetum ¹ Camilly V. Campanharo ¹ Danielle R. da Silva ¹ Giulia M. Giacinti ¹ Iris M. da Silva ¹ João Augusto D. Moura ¹ Karen Ruth M. Barbosa ¹ Lorena S. Altoé ¹ Lorena S. Mauricio ¹ Luíza S. Góes ² Lyvia N. Alves ¹ Sarah Sophia G. Linhares ³ Vinícius d. Ventorim ¹ Yasmin M. Guaitolini ¹ Eldamária d. dos Santos ¹ Flavia I. Errera ¹ Sonia Groisman ⁴ ELIZEU CARVALHO ⁴ Flavia de Paula ¹ Pierre B. Fechine ⁵ Iuri D. Louro ¹

• ¹ Federal University of Espirito Santo, Vitória, Brazil
• ² Grupo de Bioanalítica, Microfabricação e Separações (BioMicS), São Carlos-SP, Brazil
• ³ Laboratório de Estudos Neuroquímicos, Universidade Federal do Rio Grande do Norte (UFRN), Rio Grande do Norte, Brazil., Brazil
• ⁴ Roberto Alcantara Gomes Institute of Biology, State University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil
• ⁵ Department of Analytical Chemistry and Physical Chemistry, Science Center, Federal University of Ceara, Fortaleza, Ceará, Brazil

Cancer therapy is facing increasingly significant challenges, marked by a wide range of techniques and research efforts centered around somatic mutations, precision oncology, and the vast amount of big data. Despite this abundance of information, the quest to cure cancer often seems more elusive, with the "war on cancer" yet to deliver a definitive victory. A particularly pressing issue is the development of tumor treatment resistance, highlighting the urgent need for innovative approaches. Evolutionary, Quantum Biolgy and System Biology offer a promising framework for advancing experimental cancer research. By integrating theoretical studies, translational methods, and flexible multidisciplinary clinical research, there's potential to enhance current treatment strategies and improve outcomes for cancer patients. Establishing stronger links between evolutionary, quantum, entropy and chaos principles and oncology could lead to more effective treatments that leverage an understanding of the tumor's evolutionary dynamics, paving the way for novel methods to control and mitigate cancer. Achieving these objectives necessitates a commitment to multidisciplinary and interprofessional collaboration at the heart of both research and clinical endeavors in oncology. This entails dismantling silos between disciplines, encouraging open communication and data sharing, and integrating diverse viewpoints and expertise from the outset of research projects. Being receptive to new scientific discoveries and responsive to how patients react to treatments is also crucial. Such strategies are key to keeping the field of oncology at the forefront of effective cancer management, ensuring patients receive the most personalized and effective care. Ultimately, this approach aims to push the boundaries of cancer understanding, treating it as a manageable chronic condition, aiming to extend life expectancy and enhance patient quality of life.